CARDIFF ONCOLOGY, INC. Conversion of Stock, Shares Issued
CARDIFF ONCOLOGY, INC. (CRDF) reported Conversion of Stock, Shares Issued of 1.34 million shares for the 1-month period ending 2022-10-31, per its 10-K filed 2023-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2023-03-02
- CARDIFF ONCOLOGY, INC. conversion of stock, shares issued for the quarter ending 2019-09-30 was 0.00 shares.
| Period end | Conversion of Stock, Shares Issued 1 month | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 161 month |
|---|---|---|---|---|---|
| 2022-10-31 | 1.34M shares 10-K · filed 2023-03-02 | ||||
| 2022-01-31 | 1.34M shares 10-K · filed 2023-03-02 | ||||
| 2020-06-30 | 1.55M shares 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 333.33K shares 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 333.33K shares 10-Q · filed 2019-08-08 | ||||
| 2019-04-30 | 333.33K shares 10-K · filed 2021-02-25 | ||||
| 2012-12-31 | 137.74K shares 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |